Estrostep 21 (Norethindrone Acetate and Ethinyl Estradiol) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 21, 2022 Category: Drugs & Pharmacology Source Type: news
Aurovela (Norethindrone Acetate and Ethinyl Estradiol Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 25, 2021 Category: Drugs & Pharmacology Source Type: news
Oriahnn (Elagolix, Estradiol, and norethindrone acetate capsules; elagolix capsules) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 13, 2021 Category: Drugs & Pharmacology Source Type: news
Fyavolv (norethindrone acetate and ethinyl estradiol)
Title: Fyavolv (norethindrone acetate and ethinyl estradiol)Category: MedicationsCreated: 7/13/2021 12:00:00 AMLast Editorial Review: 7/13/2021 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - July 13, 2021 Category: Drugs & Pharmacology Source Type: news
Estrostep Fe (Norethindrone Acetate and Ethinyl Estradiol Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 13, 2021 Category: Drugs & Pharmacology Source Type: news
Myfembree (Relugolix, Estradiol, and Norethindrone Acetate Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 2, 2021 Category: Drugs & Pharmacology Source Type: news
Oriahnn (Elagolix, Estradiol, and norethindrone acetate capsules; elagolix capsules) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 10, 2020 Category: Drugs & Pharmacology Source Type: news
FDA Approves Oriahnn (elagolix/estradiol/norethindrone acetate and elagolix) for the Management of Heavy Menstrual Bleeding Due to Uterine Fibroids in Pre-Menopausal Women
NORTH CHICAGO, Ill., May 29, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV), in cooperation with Neurocrine Biosciences, Inc. (Nasdaq: NBIX), announced that the U.S. Food and Drug Administration (FDA) approved Oriahnn (elagolix, estradiol, and... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 29, 2020 Category: Drugs & Pharmacology Source Type: news
Fyavolv (Norethindrone Acetate and Ethinyl Estradiol Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 18, 2020 Category: Drugs & Pharmacology Source Type: news
Activella (Estradiol, Norethindrone Acetate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 21, 2020 Category: Drugs & Pharmacology Source Type: news
Blisovi 24 Fe (Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 16, 2020 Category: Drugs & Pharmacology Source Type: news
Lopreeza (Estradiol/Norethindrone Acetate Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 15, 2020 Category: Drugs & Pharmacology Source Type: news
Amabelz (Estradiol And Norethindrone Acetate Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 1, 2019 Category: Drugs & Pharmacology Source Type: news
Taytulla (Norethindrone Acetate and Ethinyl Estradiol) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 13, 2019 Category: Drugs & Pharmacology Source Type: news
Lupin Pharmaceuticals Inc. Announces a Nationwide Recall of Mibelas & #8482; 24 Fe (Norethindrone Acetate and EthinylEstradiol 1mg/0.02mg Chewable Tablets and Ferrous Fumarate 75 mg) Tablets Due to Out of Sequence Tablets and Missing Expiry/Lot Information
Baltimore, Maryland, Lupin Pharmaceuticals Inc. announced today that it has voluntarily recalled lot L600518, Exp 05/18 of Mibelas 24 Fe (Norethindrone Acetate and Ethinyl Estradiol 1 mg/0.02 mg chewable and ferrous fumarate 75 mg) Tablets at the consumer level. A confirmed market complaint indicated a packaging error, where the blister was rotated 180 degrees within the wallet, reversing the weekly tablet orientation and making the lot number and expiration date no longer visible. The first four days of therapy would have had four non-hormonal placebo tablets as opposed to the active tablets. (Source: FDA Center for Drug ...
Source: FDA Center for Drug Evaluation and Research - What's New - June 4, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news
